Thyroid function during the rebound phase following the discontinuation of antithyroid drugs.
D000818:Animals; D003677:Deficiency Diseases / Q000378:metabolism; D004105:Diiodotyrosine / Q000096:biosynthesis*; D006801:Humans; D007455:Iodine; D010472:Perchlorates / Q000494:pharmacology; D011441:Propylthiouracil / Q000494:pharmacology*; D051381:Rats; D013375:Substance Withdrawal Syndrome; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism*; D013974:Thyroxine / Q000096:biosynthesis*; D014284:Triiodothyronine / Q000096:biosynthesis*; D014443:Tyrosine / Q000096:biosynthesis*
D010472:Perchlorates; D014284:Triiodothyronine; D014443:Tyrosine; D004105:Diiodotyrosine; D011441:Propylthiouracil; D007455:Iodine; D013974:Thyroxine